Normothermic Extracorporeal Perfusion as a Method of Donor Heart Conditioning in Experiment
- Authors: Ermolaev P.A.1, Khramykh T.P.1, Barskaya L.O.1
-
Affiliations:
- Omsk State Medical University
- Issue: Vol 33, No 2 (2025)
- Pages: 203-212
- Section: Original study
- URL: https://journals.rcsi.science/pavlovj/article/view/313108
- DOI: https://doi.org/10.17816/PAVLOVJ611151
- EDN: https://elibrary.ru/BBIXNA
- ID: 313108
Cite item
Abstract
INTRODUCTION: Extracorporeal perfusion of transplants is a promising area that is actively studied to eliminate the existing shortage of donor organs. However, the optimal parameters and duration of extracorporeal perfusion that would not lead to impairment of the morphofunctional condition of transplants, have not been sufficiently studied.
AIM: To present the results of development and experimental testing of an original device for perfusion preservation of an isolated heart on the biomodel.
MATERIALS AND METHODS: An original perfusion device for preserving donor hearts has been developed and experimentally tested on mature outbred male rats. During 15-hour normothermic extracorporeal perfusion of the heart in the proposed device, its rhythmic and contractile function, temperature, pH of the perfusate, pressure in the aorta, hematocrit, рО2 and рСО2 in the perfusate were studied, the content of glucose, lactate, and creatine phosphokinase (CPK) activity in perfusate samples were determined.
RESULTS: During perfusion of isolated hearts, sinus rhythm was observed at a sufficient rate. Perfusate pH stayed within 7.3–7.4. Hearts were perfused at constant pressure in the aorta of 70 mm Hg in normothermic conditions (t=37°С). After stabilization of the heart function, the systolic pressure in the left ventricle was 96.0 [93.7; 98.5] mm Hg and remained without significant changes during 12 hours of perfusion; at 15 hours of perfusion, the parameter decreased by 15.0% to 82.0 [79.5; 84.2] mm Hg, p=0.01208. After stabilization of the heart function, diastolic pressure in the left ventricle was 4.0 [3.0; 5.0] mm Hg and remained without significant changes during 12 hours of perfusion; by 15 hours of perfusion, it increased 1.5 times to 6.0 [5.0; 7.0] mm Hg, p=0.0164. During the experiment, biochemical markers in the perfusate after 30 min of perfusion and stabilization were at the level of physiological values without significant dynamics within 12 hours of perfusion: glucose consumption was 80.5 [70.2; 85.5] μmol/(kg×min×mm Hg); lactate excretion — 35.7 [32.5; 44.2] μmol/(kg×min×mm Hg); CPK leakage — 95.8 [93.7; 111.3] IU/l. After 15 hours of perfusion, the level of glucose consumption by isolated hearts per unit of performed function increased significantly to 136.8 [130.5; 145.7] μmol/(kg×min×mm Hg), p=0.01208; lactate excretion and CPK leakage into the perfusate increased to 58.2 [55.7; 67.4] μmol/(kg×min×mm Hg), p=0.02144, and 229.7 [215.8; 242.4] IU/L respectively, p=0.01208.
CONCLUSION: The study showed that extracorporeal perfusion of the heart in the developed device allows maintaining its viability for 12 hours in conditions maximally close to physiological ones, and also conducting dynamic assessment of the functional and metabolic state of the organ.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Pavel A. Ermolaev
Omsk State Medical University
Author for correspondence.
Email: yermol@inbox.ru
ORCID iD: 0000-0001-8733-6102
SPIN-code: 9431-9200
MD, Cand. Sci. (Medicine)
Russian Federation, OmskTatyana P. Khramykh
Omsk State Medical University
Email: khramykh@yandex.ru
ORCID iD: 0000-0002-5508-6679
SPIN-code: 6932-9968
MD, Dr. Sci. (Medicine), Assistant Professor
Russian Federation, OmskLyubov O. Barskaya
Omsk State Medical University
Email: barsik492@yandex.ru
ORCID iD: 0000-0002-0460-4296
SPIN-code: 3080-5040
MD, Cand. Sci. (Medicine)
Russian Federation, OmskReferences
- Gautier SV, Zacharevich VM, Khalilulin TA, et al. Heart transplantation as a radical method of restoring the quality of life in recipients with end-stage heart failure. Russian Journal of Transplantology and Artificial Organs. 2019;21(2):7–15. doi: 10.15825/1995-1191-2019-2-7-15 EDN: DLTATA
- Wilhelm MJ. Long-term outcome following heart transplantation: current perspective. J Thorac Dis. 2015;7(3):549–551. doi: 10.3978/j.issn.2072-1439.2015.01.46
- Kobashigawa J, Khush K, Colvin M, et al. Report from the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States. Am J Transplant. 2017;17(10):2559–2566. doi: 10.1111/ajt.14354
- Bagnenko SF, Moysyuk YG, Skvortsov AE, et al. Rehabilitation of organ from deceased donors. New preservation trend or new paradigm in transplantology? Russian Journal of Transplantology and Artificial Organs. 2009;11(3):17–29. EDN: KVUMNX
- Chew HC, Macdonald PS, Dhital KK. The donor heart and organ perfusion technology. J Thorac Dis. 2019;11(Suppl 6):S938–S945. doi: 10.21037/jtd.2019.02.59
- Messer S, Ardehali A, Tsui S. Normothermic donor heart perfusion: current clinical experience and the future. Transpl Int. 2015;28(6):634–642. doi: 10.1111/tri.12361
- Jing L, Yao L, Zhao M, et al. Organ preservation: from the past to the future. Acta Pharmacol Sin. 2018;39(5):845–857. doi: 10.1038/aps.2017.182 EDN: YHPXFB
- Stamp NL, Shah A, Vincent V, et al. Successful Heart Transplant after Ten Hours Out-of-body Time using the TransMedics Organ Care System. Heart Lung Circ. 2015;24(6):611–613. doi: 10.1016/j.hlc.2015.01.005
- Leprince P, Popov AF, Simon AR, et al. Ex vivo perfusion of the heart with the use of the Organ Care System. Eur J Cardiothorac Surg. 2016;49(5):1318–1320. doi: 10.1093/ejcts/ezw075
- Ardehali A, Esmailian F, Deng M, et al. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): A prospective, open-label, multicentre, randomised non-inferiority trial. Lancet. 2015;385(9987):2577–2584. doi: 10.1016/s0140-6736(15)60261-6
- Patent RUS No. 2 441 608 C1. 10.02.2012. Byul. No. 4. Got’e SV, Bagnenko SF, Mojsjuk JG, et al. Method for restoration and maintenance of vitality of an ischemically damaged donor organ. Available from: https://patents.google.com/patent/RU2441608C1/ru (In Russ.) EDN: WCFNNG
- Reznik ON, Skvortsov AE, Lopota AV, et al. Perfusion device for liver preservation ex vivo before transplantation: first experimental study. Russian Journal of Transplantology and Artificial Organs. 2017;19(1):35–40. doi: 10.15825/1995-1191-2017-1-35-40 EDN: YMZHTH
- Patent RUS No. 2491963. 10.09.2013. Byul. No. 25. Korolev DV, Galagudza MM, Ostashev VB, et al. Installation for perfusion of isolated heart by Langerdorf. Available from: https://yandex.ru/patents/doc/RU2491963C1_20130910 (In Russ.) EDN: USPEJO
- Patent RUS No. 2754592. 03.09.2021. Byul. No. 25. Ermolaev PA, Khramykh TP, Korpacheva OV, et al. Apparatus for perfusion preservation and reconditioning of a donor heart. Available from: https://yandex.ru/patents/doc/RU2754592C1_20210903 (In Russ.) EDN: YGEGSG
- López–Jiménez F, Paniagua D, Lamas GA. La interpretacion de los ensayos clinicos negatovos [The interpretation of negative randomized clinical trials]. Rev Invest Clin. 1998;50(5):435–440. (In Spanish)
- Monteagudo Vela M, García Sáez D, Simon AR. Current approaches in retrieval and heart preservation. Ann Cardiothorac Surg. 2018;7(1):67–74. doi: 10.21037/acs.2018.01.06
- Merkin NA, Vol’gushev VE, Andronov SP, et al. Technologies of donor organ storage by the example of a donor heart. Status and prospects. Transplantologiya. The Russian Journal of Transplantation. 2016;(1):29–35. EDN: WAQGEL
- Zhulkov MO, Fomichev AV, Alsov SA, et al. Current state of the problem and results of ex vivo perfusion of donor hearts. Russian Journal of Transplantology and Artificial Organs. 2019;21(4):143–146. doi: 10.15825/1995-1191-2019-4-143-146 EDN: BTFOPO
- Jain P, Prichard RA, Connellan MB, et al. Long distance heart transplantation: a tale of two cities. Intern Med J. 2017;47(10):1202–1205. doi: 10.1111/imj.13568
Supplementary files
